Expo Hub
Alzheimer's Day
Empowering hope
March 5, 2026
Empowering hope
Alzheimer’s disease is a growing global emergency affecting millions of lives. Now – with the emergence of new disease-modifying therapies (DMTs) that can slow cognitive decline – there is renewed hope. The inaugural Alzheimer’s Day at ECR 2026 demonstrated how to deliver that hope to patients and their loved ones along every step of the Alzheimer’s care pathway.
Watch the recordings below for a day filled with exciting sessions presented by thought leaders. The sessions move from a clinical overview of dementia and the basics of Alzheimer's imaging to cutting-edge techniques that support diagnosis and clinical decision-making as well as ARIA Imaging in the era of new therapies. And the important question: how ready are healthcare systems for the paradigm shift in Alzheimer’s disease in this new era of DMTs?
Watch the recordings from Siemens Healthineers
Alzheimer's Day 2026
1 / 0
Dementia: From Symptoms to Treatment - A Clinical Overview
This session provides a concise overview of dementia with a focus on Alzheimer’s disease, covering epidemiology, risk factors, subtypes, pathophysiology, prevention, and stepwise diagnosis from clinical assessment to CSF and emerging blood biomarkers.
Alzheimer's Imaging: Starting with the Basics
This session highlights the role of MRI and PET in the diagnostic evaluation of Alzheimer’s disease, covering MRI protocols, characteristic imaging findings, and volumetric analysis for diagnosis and disease monitoring.
Differential Diagnosis of Alzheimer's disease
This session provides an overview of how MRI and PET help differentiate Alzheimer’s disease from other dementias, highlighting key imaging patterns, common pitfalls, characteristic atrophy and metabolic signatures, and the use of different tracers to strengthen diagnostic confidence in clinical practice.
Advanced Imaging in Dementia
This session explores advanced and next-generation imaging in dementia, including diffusion and perfusion techniques, susceptibility imaging, arterial spin labeling, and emerging technologies such as ultra-low- and high-field MRI, PET/MR, as well as AI applications.
ARIA Imaging in the era of new therapies
This session provides a comprehensive, case-based overview of Amyloid-Related Imaging Abnormalities (ARIA) in patients receiving anti-amyloid therapies, covering underlying mechanisms, risk factors and management. It also highlights recommended MRI protocols, characteristic imaging findings and severity grading through interactive case discussions.
Healthcare System Readiness in the era of DMTs
This session examines how healthcare systems and radiology centers can prepare for the new era of Alzheimer’s care, focusing on the integration of disease-modifying therapies, advanced diagnostics, reimbursement and readiness challenges, workflow optimization and multidisciplinary coordination.
1 / 0
Alzheimer’s Care Pathway
Follow Rose on her journey
Alzheimer's disease
Learn how MRI can help in Alzheimer's disease follow-up.
BIOGRAPH One*
Shape the new era
PET imaging for Alzheimer's disease
Siemens Healthineers PETNET, positioned to support the identification of Alzheimer's disease in its earliest stages.
PET/CT scanners
Set the standard in PET/CT with our BiographPET/CT family.
* BIOGRAPH One is pending 510(k) clearance and is not yet commercially available in the U.S.A. Its future availability cannot be guaranteed